CLINICAL USEFULNESS OF THE NOVEL MARKER BLCA-4 FOR THE DETECTION OF BLADDER CANCER
- 1 September 2000
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 164, 634-639
- https://doi.org/10.1097/00005392-200009010-00004
Abstract
Previous studies at our laboratory identified 6 bladder cancer specific nuclear matrix proteins termed BLCA-1 to 6. We recently developed an immunoassay that detects the bladder cancer specific nuclear matrix protein BLCA-4. We analyzed urine samples from patients with bladder cancer, those with spinal cord injury and normal volunteers to determine the BLCA-4 level in these 3 groups. Urine samples obtained from 51 normal controls, and 54 patients with bladder cancer and 202 with spinal cord injury were tested for BLCA-4. We evaluated the association of BLCA-4 level with tumor grade and stage, urine cytology and bladder cancer history in the nonspinal cord injured population. Similarly we compared parameters associated with BLCA-4, such as spinal cord injury duration, catheterization, history of urinary tract infection, smoking and urine culture, in spinal cord injured patients. We established a normal cutoff point of 13 optical density units per microg. protein for the BLCA-4 assay. The BLCA-4 level was less than the cutoff in all 51 normal controls, while in 53 of the 55 urine samples (96.4%) of patients with bladder cancer and 38 of the 202 (19%) of spinal cord injured patients urinary BLCA-4 was greater than the cutoff. There was no correlation of any individual factors studied in these cases, including urinary tract infection and urinary BLCA-4. Elevated urinary BLCA-4 levels may accurately identify bladder cancer and distinguish these patients from normal individuals. There is no correlation of urinary BLCA-4 with a history of urinary tract infection, smoking, catheterization or cystitis considered independently. Urinary BLCA-4 determination appears to have high potential as a test for screening and monitoring bladder cancer in the general population and in groups at high risk for the disease, such as those with spinal cord injury.Keywords
This publication has 15 references indexed in Scilit:
- Role of chronic catheterization in the development of bladder cancer in patients with spinal cord injuryUrology, 1999
- Update on urine-based markers for bladder cancerPostgraduate Medicine, 1999
- Screening Cystoscopy and Survival of Spinal Cord Injured Patients With Squamous Cell Cancer of the BladderJournal of Urology, 1997
- Results of bard bta test in monitoring patients with a history of transitional cell cancer of the bladderUrology, 1997
- Utilization of Nuclear Matrix Proteins for Cancer DiagnosisCritical Reviews™ in Eukaryotic Gene Expression, 1996
- Malignant Vesical Tumors Following Spinal Cord InjuryJournal of Urology, 1987
- Bladder cancer after spinal cord injurySpinal Cord, 1981
- Bladder Cancer and Squamous Metaplasia in Spinal Cord Injury PatientsJournal of Urology, 1977
- A 25-Year Prospective Mortality Study in the Spinal Cord Injured Patient: Comparison with the Long-Term Living ParaplegicJournal of Urology, 1977
- The incidence of bladder cancer in paraplegiaSpinal Cord, 1966